NRA-DAPAGLIFLOZIN

ਉਤਪਾਦ ਝਲਕ

About NRA-DAPAGLIFLOZIN

NRA-DAPAGLIFLOZIN is a prescription medication containing the active ingredient Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It is used to treat type 2 diabetes mellitus (T2DM) and is indicated for the improvement of glycemic control in adults with T2DM.

Key Benefits & Uses

• Improves glycemic control in adults with type 2 diabetes mellitus (T2DM)
• Helps to lower blood sugar levels and improve insulin sensitivity
• May be used in combination with other medications to treat T2DM

Active Ingredient & Action

Dapagliflozin works by inhibiting the SGLT2 protein in the kidneys, which reabsorbs glucose back into the bloodstream. By blocking this protein, Dapagliflozin increases the excretion of glucose in the urine, thereby lowering blood sugar levels.

Important Notes

Before taking NRA-DAPAGLIFLOZIN, inform your doctor if you have any kidney problems, as Dapagliflozin may worsen kidney function. It is also essential to monitor your blood sugar levels regularly while taking this medication. Do not use NRA-DAPAGLIFLOZIN if you are pregnant or breastfeeding, as its safety in these situations has not been established.